Aspire BioPharma (ASBP) EBITDA

Annual EBITDA

-$358.60 K
+$237.90 K+39.88%

December 1, 2023

Summary

Performance

1-Year Change

+39.88%

3-Year Change

+39.88%

5-Year Change

+39.88%

15-Year Change

+39.88%

ASBP EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$358.60 K
ASBP annual EBITDA is currently at an all-time high

3-Year Low

-$596.50 K

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2023
ASBP previous annual earnings announcement was published on Dec 1, 2023

Next Annual Earnings Report Date

N/A
ASBP next annual earnings announcement has not yet been scheduled

OtherASBPprofitabilitymetrics:

Annual Revenue

-
ASBP annual revenue value is unknown

Annual Net Income

-$359.10 K
ASBP annual net profit is -$359.10 thousand

Annual EBIT

-$358.60 K
ASBP annual earnings before interest & taxes is -$358.60 thousand

Annual EPS

-$0.01
ASBP annual earnings per share is -$0.01

Quarterly EBITDA

-$242.60 K
-$145.70 K-150.36%

September 1, 2024

Summary

Performance

3-Month Change

-150.36%

1-Year Change

-150.36%

3-Year Change

-150.36%

5-Year Change

-150.36%

ASBP Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$65.50 K

3-Year Low

-$242.60 K
ASBP quarterly EBITDA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
ASBP previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
ASBP next earnings announcement has not yet been scheduled

OtherASBPprofitabilitymetrics:

Quarterly Revenue

-
ASBP quarterly revenue value is unknown

Quarterly Net Income

-$243.60 K
ASBP quarterly net profit is -$243.60 thousand

Quarterly EBIT

-$242.60 K
ASBP quarterly earnings before interest & taxes is -$242.60 thousand

Quarterly EPS

-$0.01
ASBP quarterly earnings per share is -$0.01

TTM EBITDA

-$415.80 K
-$177.10 K-74.19%

September 1, 2024

Summary

Performance

3-Month Change

-74.19%

1-Year Change

-74.19%

3-Year Change

-74.19%

5-Year Change

-74.19%

ASBP TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$90.30 K

3-Year Low

-$415.80 K
ASBP TTM EBITDA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
ASBP previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
ASBP next earnings announcement has not yet been scheduled

OtherASBPprofitabilitymetrics:

TTM Revenue

-
ASBP TTM revenue value is unknown

TTM Net Income

-$417.30 K
ASBP TTM net profit is -$417.30 thousand

TTM EBIT

-$415.80 K
ASBP TTM earnings before interest & taxes is -$415.80 thousand

TTM EPS

-$0.01
ASBP TTM earnings per share is -$0.01

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$358.60 K
ASBP annual EBITDA is -$358.60 thousand

Annual Net Income

-$359.10 K
ASBP annual net profit is -$359.10 thousand

Annual Interest Expense

$0.00
ASBP annual interest expense is $0.00

Annual Income Tax

$500.00
ASBP annual income tax is $500.00

Annual D&A

$0.00
ASBP annual depreciation & amortization is $0.00

ASBP EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+39.9%-150.4%-74.2%
3 y3 years+39.9%-150.4%-74.2%
5 y5 years+39.9%-150.4%-74.2%

ASBP EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+66.3%+270.4%at low+360.5%at low
5 y5-yearat high+66.3%+270.4%at low+360.5%at low
alltimeall timeat high+66.3%+270.4%at low+360.5%at low

Aspire BioPharma EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$242.60 K(+150.4%)
-$415.80 K(+74.2%)
Jun 2024
-
-$96.90 K(+27.0%)
-$238.70 K(+2.8%)
Dec 2023
-$358.60 K
-$76.30 K(+16.5%)
-$232.10 K(+49.0%)
DateAnnualQuarterlyTTM
Sep 2023
-
-$65.50 K(-27.5%)
-$155.80 K(+72.5%)
Jun 2023
-
-$90.30 K
-$90.30 K
Dec 2022
-$596.50 K
-
-

FAQ

  • What is Aspire BioPharma annual EBITDA?
  • What is the all time high annual EBITDA for Aspire BioPharma?
  • What is Aspire BioPharma annual EBITDA year-on-year change?
  • What is Aspire BioPharma quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Aspire BioPharma?
  • What is Aspire BioPharma quarterly EBITDA year-on-year change?
  • What is Aspire BioPharma TTM EBITDA?
  • What is the all time high TTM EBITDA for Aspire BioPharma?
  • What is Aspire BioPharma TTM EBITDA year-on-year change?

What is Aspire BioPharma annual EBITDA?

The current annual EBITDA of ASBP is -$358.60 K

What is the all time high annual EBITDA for Aspire BioPharma?

Aspire BioPharma all-time high annual EBITDA is -$358.60 K

What is Aspire BioPharma annual EBITDA year-on-year change?

Over the past year, ASBP annual EBITDA has changed by +$237.90 K (+39.88%)

What is Aspire BioPharma quarterly EBITDA?

The current quarterly EBITDA of ASBP is -$242.60 K

What is the all time high quarterly EBITDA for Aspire BioPharma?

Aspire BioPharma all-time high quarterly EBITDA is -$65.50 K

What is Aspire BioPharma quarterly EBITDA year-on-year change?

Over the past year, ASBP quarterly EBITDA has changed by -$145.70 K (-150.36%)

What is Aspire BioPharma TTM EBITDA?

The current TTM EBITDA of ASBP is -$415.80 K

What is the all time high TTM EBITDA for Aspire BioPharma?

Aspire BioPharma all-time high TTM EBITDA is -$90.30 K

What is Aspire BioPharma TTM EBITDA year-on-year change?

Over the past year, ASBP TTM EBITDA has changed by -$177.10 K (-74.19%)